More Fake Cancer Drugs Found In The U.S. | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

More Fake Cancer Drugs Found In The U.S.

Another batch of phony cancer drugs has made its way into the U.S., the Food and Drug Administration says.

U.S.-based medical practices purchased vials of counterfeit medicine labeled as Altuzan from a foreign supplier, FDA spokesperson Shelly Burgess tells Shots. She said the agency doesn't have any reports of patients having received the counterfeit drugs.

Altuzan is the Turkish brand name for Avastin, the FDA-approved blockbuster cancer drug from Swiss drugmaker Roche's Genentech unit. Altuzan is approved for use in Turkey — but not in the U.S.

The shipments came from Richards Pharma, a foreign supplier also known by the names Richards Services, Warwick Healthcare Solutions and Ban Dune Marketing, according to an FDA statement. Lab tests confirmed March 15 that the vials contained none of the active ingredient in Altuzan, Burgess says.

Packaging or vials found in the U.S. that claim to be Roche's Altuzan with lot number B6021 should be considered counterfeit, the FDA statement says.

As Richard Knox reported in Shots, counterfeit Avastin turned up in the U.S. in February. More than a dozen specialists in Illinois, California and Texas were thought to have bought it. Avastin, or bevacizumab, is approved to treat colorectal, lung, kidney and brain cancer.

Avastin is expensive — a 400-milligram vial costs $2,400, and sales of the drug totaled more than $2.5 billion last year.

Fake versions of diet drugs, the cholesterol drug Lipitor and the flu medication Tamiflu also have turned up in the U.S. in the past.

"In the past three months, we've notified health care providers about the risk of purchasing unapproved injectable cancer medications from unlicensed sources," Burgess says. "This is a practice that has to stop."

She says health care providers or patients who think they have received counterfeit drugs should report it to the FDA's MedWatch safety program.

Copyright 2012 National Public Radio. To see more, visit http://www.npr.org/.

NPR

Former Basketball Player Scores As A Filmmaker

While Deon Taylor was playing professional basketball in Germany, he had an epiphany: he wanted to make movies. The self-taught director's latest film, Supremacy, was released this Friday.
NPR

Surströmming Revisited: Eating Sweden's Famously Stinky Fish

Sweden has the distinction of producing surströmming, one of the foulest-smelling foods in the world. More than a decade ago, NPR's Ari Shapiro tried eating it and failed. It's time for a rematch.
NPR

What Romney's Retreat Means For GOP Hopefuls

NPR's Scott Simon speaks with senior Washington editor Ron Elving about the narrowing Republican presidential field for 2016 and what we've seen so far in the first month of the new Congress.
NPR

The Infinite Whiteness Of Public Radio Voices

The hashtag #publicradiovoices, about the "whiteness" of public radio, trended on Twitter this week. NPR's Scott Simon speaks with Gene Demby of NPR's Code Switch team about the conversation.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.